Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
Vitiligo is an autoimmune skin disease presenting with areas of depigmentation. Recent reports suggest that Janus kinase (JAK) inhibitors may be an effective therapy. In this case report, we show our experience with an adolescent patient with a long history of generalized and refractory vitiligo, fo...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2021-04-01
|
| coleção: | Case Reports in Dermatology |
| Assuntos: | |
| Acesso em linha: | https://www.karger.com/Article/FullText/513938 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|